» Articles » PMID: 12359745

Recurrent Rearrangement of the Ewing's Sarcoma Gene, EWSR1, or Its Homologue, TAF15, with the Transcription Factor CIZ/NMP4 in Acute Leukemia

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Oct 3
PMID 12359745
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Fusions of the TET-proteins (TLS/FUS, EWSR1, and TAF15/RBP56) to different transcription factors are involved in various malignancies including Ewing's sarcoma, primitive neuroectodermal tumors, and acute myeloid leukemia. These are thought to arise through transcriptional deregulation, with the transcription factor defining the tumor phenotype. We show that, as result of a t(12;17)(p13;q11) or its variant t(12;22)(p13;q12), the transcription factor gene CIZ/NMP4 is recurrently involved in acute leukemia through fusion with either EWSR1 or TAF15. The fusions possess transforming properties in NIH3T3 cells but do not affect the expression of CIZ target genes, suggesting a contribution to oncogenesis that is independent of the transactivating properties of the fusion protein. These results also extend the involvement of TET-protein fusions to acute lymphoblastic leukemia and suggest a role for CIZ/NMP4 in lymphoid and myeloid development.

Citing Articles

Tata-box-binding protein-associated factor 15 as a new potential marker in gastrointestinal tumors.

Elpek G World J Gastroenterol. 2024; 30(28):3367-3372.

PMID: 39091718 PMC: 11290397. DOI: 10.3748/wjg.v30.i28.3367.


Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of With .

Panagopoulos I, Andersen K, Wik H, Tandsaether M, Micci F, Heim S Cancer Genomics Proteomics. 2023; 20(4):354-362.

PMID: 37400142 PMC: 10320562. DOI: 10.21873/cgp.20387.


ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.

Zhu L, Bai W, Cheng Q, Fang J Cancer Control. 2023; 30:10732748231182787.

PMID: 37306722 PMC: 10272635. DOI: 10.1177/10732748231182787.


RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).

Rehn J, Mayoh C, Heatley S, McClure B, Eadie L, Schutz C PLoS Genet. 2022; 18(10):e1010300.

PMID: 36251721 PMC: 9612819. DOI: 10.1371/journal.pgen.1010300.


Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.

Yasuda T, Sanada M, Tsuzuki S, Hayakawa F Cancer Sci. 2022; 114(1):8-15.

PMID: 36106363 PMC: 9807527. DOI: 10.1111/cas.15583.